Abstract
Scutellaria barbata (skullcap) has been used in traditional Chinese and Korean medicine for treating various inflammation illnesses and cancers. In vitro studies have demonstrated the anti-mutagenesis (chemo-preventive) effect of skullcap via modulating the metabolism of mutagenic compounds such as aflatoxin B1 and benzo[a]pyrene to reduce their DNA binding efficiency. In vitro and in vivo studies using flavonoid compound of skullcap in both human and animal models have shown promising anticancer effects. The aqueous extract of skullcap has shown to have the most effective anticancer chemical constituents. In vitro studies indicated that skullcap might be effective against all three stages of carcinogenesis (initiation, promotion, and progression). It has also been found to exert anticancer mechanisms such as anti-inflammation, anti-proliferation, induction of apoptosis against numerous cancer cell lines including digestive (liver and colorectal), respiratory (lung and nasopharyngeal), and lymphatic (leukemia) systems, and induction of sex hormone-specific glycolytic necrosis, especially those of the reproductive system (breast, uterine, and prostate) while inactive on normal human mammary epithelial cells. In vivo murine model showed aqueous extract of skullcap may enhance macrophage cell line activity leading to inhibition of tumor growth. It has also been shown to inhibit aberrant crypt formation in colon, delay prostate cancer development and progression in transgenic adenocarcinoma of mouse prostate mice, and reduced solid ascites tumor proliferation in the breast of mice. Aqueous extracts of skullcap have been found to have a favorable toxicity profile when used as an oral feeding in Phase 1 and 1B clinical studies in metastatic breast cancer patients. Based on the studies reported on skullcap, the best prospective therapeutic application of skullcap would be in breast, prostate, liver, colorectal, uterine, and lung cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bui-Xuan, N. H., Tang, P. M., Wong, C. K., et al. (2010). Photo-activated pheophorbide-a, an active component of Scutellaria barbata, enhances apoptosis via the suppression of ERK-mediated autophagy in the estrogen receptor-negative human breast adenocarcinoma cells MDA-MB-231. Journal of Ethnopharmacology, 13, 95–103.
Campbell, M. J., Hamilton, B., Shoemaker, M., et al. (2002). Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Research, 22, 3843–3852.
Cha, Y., Lee, E., Lee, H., et al. (2004). Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathways. Clinica Chimica Acta; International Journal of Clinical Chemistry, 348, 41–48.
Chan, J. Y., Tang, P. M., Hon, P. M., et al. (2006). Pheophorbide-a, a major anti-cancer component purified from Scutellaria barbata, induces apoptosis in human hepatocellular carcinoma. Planta Medica, 72, 28–33.
Chen, L. G., Hung, L. Y., Tsai, K. W., et al. (2008). Wogonin, a bioactive flavonoid in herbal teainhibits inflammatory cyclooxygenase-2 gene expression in human lung epithelial cancer cells. Molecular Nutrition & Food Research, 52, 1349–1357.
Chong, S. C., & Lee H. (1988). Chinese medicinal herbs of Hong Kong. Hong Kong: Commercial Press.
Chui, C. H., Lau, F. Y., Tang, J. C., et al. (2005). Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. International Journal of Molecular Medicine, 16, 337–341.
Dai, S. J., Chen, M., Liu, K., et al. (2006a). Four new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Chemical & Pharmaceutical Bulletin (Tokyo), 54, 869–872.
Dai, S. J., Tao, J. Y., Liu, K., et al. (2006b). Neo-clerodane diterpenoids from Scutellaria barbata with cytotoxic activities. Phytochemistry, 67, 1326–1330.
Dai, S. J., Sun, J. Y., Ren, Y., et al. (2007a). Bioactive ent-clerodane diterpenoids from Scutellaria barbata. Planta Medica, 73, 1217–1220.
Dai, S. J., Wang, G. F., Chen, M., et al. (2007b). Five new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Chemical & Pharmaceutical Bulletin (Tokyo), 55, 1218–1221.
Dai, S. J., Shen, L., & Ren, Y. (2008). Two new neo-clerodane diterpenoids from Scutellaria barbata. Journal of Integrrative Plant Biology, 50, 699–702.
Dai, Z. J., Liu, X. X., Xue, Q., et al. (2008a). Anti-proliferative and apoptosis-inducing activity of Scutellaria barbata drug-containing serum on mouse’s hepatoma H22 cells. Zhong Yao Cai, 31, 550–553.
Dai, Z. J., Wang, X. J., Xue, Q., et al. (2008b). Effects of Scutellaria barbata drug-containing serum on apoptosis and mitochondrial transmembrane potential of hepatoma H22 cells. Zhong Xi Yi Jie He Xue Bao, 6, 821–826.
Dai, Z. J., Wang, Z. J., Li, Z. F., et al. (2008c). Scutellaria barbata extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World Journal of Gastroenterology: WJG, 14, 7321–7328.
Dai, S. J., Pheng, W. B., Shen, L., et al. (2009a). Two new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Journal of Asian Natural Products Research, 11, 451–456.
Dai, S. J., Pheng, W. B., Zhang, D. W., et al. (2009b). Cytotoxic neo-clerodane diterpenoids alkaloids from Scutellaria barbata. Journal of Natural Products, 72, 1793–1797.
Dai, S. J., Qu, G. W., Yu, Q. Y., et al. (2010). New neo-clerodane diterpenoids from Scutellaria barbata with cytotoxic activities. Fitoterapia, 81, 737–741.
Fong, S., Shoemaker, M., Cadaoas, J., et al. (2008). Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biology & Therapy, 7, 577–586.
Gingrich, J. R., Barrios, J. R., Morton, R. A., et al. (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Research, 56, 4096–4102.
Gingrich, J. R., Barrios, J. R., Kattan, M. W., et al. (1997). Androgen-independent prostate cancer progression in the TRAMP model. Cancer Research, 57, 4687–4691.
Goh, D., Lee, Y. H., & Ong, E. S. (2005). Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. Journal of Agricultural and Food Chemistry, 53, 8197–8204.
Gupta, S., Ahmad, N., Marengo, S. R., et al. (2000). Chemoprevention of prostate carcinogenesis by x-difluoromethylornithine in TRAMP mice. Cancer Research, 60, 5125–5133.
Han, F., Hu, J., & Xu, H. (1997). Effects of some Chinese herbal medicine and green tea antagonizing mutagenesis caused by cigarette tar. Zhonghua yu fang yi xue za zhi [Chinese Journal of Preventive Medicine], 31, 71–74.
Harris, G. K., Sharra, D. C., Leonard, S. S., et al. (2003). Effects of the Chinese medicinal herb Scutellaria barbata on cyclooxygenase-2 and inducible nitric oxide synthase expression on LPS-induced RAW 264.7 cells. In: Proceedings of the 94th Annual Meeting American Association of Cancer Research, 2003 April, Washington, DC. Philadelphia, PA: AACR, 44, 1419.
Huang, K. C. (1999). The pharmacology of Chinese herbs. Boca Raton: CRC Press.
Jemal, A., Siegel, R., Ward, E., et al. (2010). Cancer statistics, 2010. C CA: A Cancer Journal for Clinicians, 60, 277–300.
Jiangsu New Medical College. (1977). Dictionary of Chinese Materia Medica. Shanghai: Science and Technology Press of Shanghai.
Kim, D., Lee, T., Lim, I., et al. (2005). Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don. in vitro: Isolation of flavonoids of apigenin and luteolon as acting compounds. Toxicology and Applied Pharmacology, 205, 213–224.
Kim, E. K., Kwon, K. B., Han, M. J., et al. (2007a). Induction of G1 arrest and apoptosis by Scutellaria barbata in the human promyeloctyic leukemia HL-60 cell line. International Journal of Molecular Medicine, 20, 123–128.
Kim, J. H., Lee, E. O., Lee, H. J., et al. (2007b). Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells. Annals of the New York Academy of Sciences, 1095, 598–611.
Kim, K. W., Jin, U. H., Kim, D. I., et al. (2008). Antiproliferation effect of Scutellaria barbata D. Don. On cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein. Phytotherapy Research: PTR, 22, 583–590.
Lau, F. Y., Chui, G. H., Gambari, R., et al. (2005). Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cell. International Journal of Molecular Medicine, 16, 1157–1162.
Lee, T. K., Cho, H. L., Kim, D. I., et al. (2004a). Scutellaria barbata D. Don induces c-fos gene expression in human uterine leiomyomal cells by activating beta2-adrenergic receptors. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 14, 526–531.
Lee, T. K., Kim, D. I., Han, J. Y., et al. (2004b). Inhibitory effects of Scutellaria barbata D. Don and Euonymus alatus Sieb aromatase activity of human leiomyomal cells. Cycle analysis. Immunopharmacology and Immunotoxicology, 26, 315–327.
Lee, T. K., Kim, D. I., Song, Y. L., et al. (2004c). Differential inhibition of Scutellaria barbata D. Don (Laminaceae) on HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacology and Immunotoxicology, 26, 329–342.
Lee, T. K., Lee, D. K., Kim, D. I., et al. (2004d). Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal proliferation through cell cycle analysis. International Immunonopharmacology, 4, 447–454.
Lee, H., Kim, Y., Choi, I., et al. (2010). Two novel neo-clerodane diterpenoids from Scutellaria barbata. Bioorganic & Medicinal Chemistry Letters, 20, 288–290.
Lin, J. M., Liu Y, & Luo R. C. (2006a). Effect of Scutellaria barbata extract against human hepatocellular Hep-G2 cell proliferation and its mechanism. Nan Fang Yi Ke Da Xue Xue Bao, 26, 975–977.
Lin, J. M., Liu, Y., & Luo, R. C. (2006b). Inhibitory effect of Scutellaria barbata extracts against human hepatocellular carcinoma cells. Nan Fang Yi Ke Da Xue Xue Bao, 26, 591–593.
Marconett, C. N., Morgenstern, T. J., San Roman, A. K., et al. (2010). BZL 101, a phytochemcial extract form the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biology & Therapy, 10, 397–405.
Newman, D. J., & Cragg, G. M. (2007). Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70, 461–477.
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003). Natural products as sources of new drugs over the period 1981–2002. Journal of Natural Products, 66, 1022–1037.
Nguyen, D. L., Devadhason, R. R., & Wong, B. Y. (2008). Dosage-dependent regulation of caspase 8 activation in LNCaP and DU145 human prostate cancer cell lines by the Chinese medicinal herb Scutellaria barbata. 7th Annual AACR International Conference of Frontiers in Cancer Prevention Research, A39.
Perez, A. T., Arun, B., Tripathy, D., et al. (2010). A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Research and Treatment, 120, 111–118.
Powell, C. B., Fung, P., Jackson, J., et al. (2003). Aqueous extract of herba Scutellaria barbatae, a Chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Gynecologic Oncology, 91, 332–340.
Rugo, H., Shtivelman, E., Perez, A., et al. (2007). Phase I trial and antitumor effects of BZL101 for patients with advance breast cancer. Breast Cancer Research: BCR, 105, 17–28.
Shoemaker, M., Hamilton, B., Dairkee, S. H., et al. (2005). In vitro anticancer activity of twelve Chinese medicinal herbs. Phytotherapy Research: PTR, 19, 649–651.
Smith, M. R., & Kantoff, P. W. (2001). Molecular biology of prostate cancer. In J. Mendelsohn, P. M. Howley, M. A. Israel, & L. A. Liotta (Eds.), The molecular basis of cancer (2nd ed., pp. 343–360). Philadelphia: WB Saunders Company.
Suh, S. J., Yoon, J. W., Lee, T. K., et al. (2007). Chemoprevention of Scutellaria barbata on human cancer cells and tumorigenesis in skin cancer. Phytotherapy Research: PTR, 21, 135–141.
Tang, P. M., Chan, J. Y., Au, S. W., et al. (2006). Pheophorbide a, an active component in Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biology & Therapy, 5, 1111–1116.
Tang, P. M., Chan, J. Y., Zhang, D. M., et al. (2007). Pheophorbide a, an active component in Scutellaria barbata, reverses P-glycoprotein-mediated multidrug resistance on a human hepatoma cell line R-HepG2. Cancer Biology & Therapy, 6, 504–509.
Tang, W., & Eisenbrand G. (1992). Chinese drugs of plant origin: Chemistry, pharmacology and use in traditional and modern medicine. Berlin: Springer.
The Pharmacopoeia Commission of PRC. (2000). Pharmacopoeia of the People’s Republic of China (English Edition). Beijing: People’s Republic of China.
Wei, P. Y., Pu, H. Q, Wei, X., et al. (2007). Apoptosis-induced effect of Scutellaria barbata extract on human lung cancer SPC-A-1 cells and the expression of apoptosis associated genes. Zhong Yao Cai, 30, 1270–1273.
Wong, B. Y., Lau, B. H., & Teel, R. W. (1992a). Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene. Phytotherapy Research: PTR, 6, 10–14.
Wong, B. Y., Lau, B. H., & Teel, R. W. (1992b). Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of benzo[a]pyrene 7,8-dihydrodiol and benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide. Cancer letters, 62, 123–131.
Wong B. Y., Lau, B. H., Tadi, P. P., et al. (1992c). Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of aflatoxin B1. Mutation Research, 279, 209–216.
Wong, B. Y., Lau, B. H., Yamasaki, T., et al. (1993a). Inhibition of dexamethasone-induced cytochrome P450-mediated mutagenicity and metabolism of aflatoxin B1 by Chinese medicinal herbs. European Journal of Cancer Prevention, 2, 351–356.
Wong, B. Y., Lau, B. H., Yamasaki, T., et al. (1993b). Modulation of cytochrome P450IA1-mediated mutagenicity, DNA binding and metabolism of benzo[a]pyrene by Chinese medicinal herbs. Cancer Letters, 68, 75–82.
Wong, B. Y., Jia, T. Y., Wan, C. P., et al. (1996). Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biotherapy & Radiopharmaceuticals, 11, 51–56.
Wong, B. Y., Nguyen, D. L., Cabrera, I. B., et al. (2007). Modulation of apoptosis via the induction of caspase 3, 8, and 9 in LNCaP cells by two Chinese medicinal herbs Scutellaria barbata and Oldenlandia diffusa. 6th Annual AACR International Conference of Frontiers in Cancer Prevention Research, 112, A135.
Wong, B. Y., Nguyen, D. L., Lin, T., et al. (2009). Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. European journal of cancer prevention: The Official Journal of the European Cancer Prevention Organisation (ECP), 18, 331–341.
Wong, B. Y., Kim, L. Y., Kim, B. Y., et al. (2010). Inhibition of azoxymethane-induced aberrant crypt foci in C57BL/6 mice by the Chinese medicinal herbs Scutellaria barbata. 101st Annual Meeting American Association of Cancer Research 2010, A5677.
Wu, Y, & Chen, D. F. (2009). Anti-complementary effect of polysaccharide B3-PS1 in Herba Scutellariae barbatae (Scutelllaria barbata). Immunopharmacology and Immunotoxicology, 30, 696–701.
Yin, X., Zhou, X., Jie, C., et al. (2004). Anti-cancer activity and mechanism of Scutellaria barbata extract on human cancer cell lines A549. Life Sciences, 75, 2233–2244.
Yu, J., Liu, H., Lei, J., et al. (2007). Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituent. Phytotherapy Research: PTR, 21, 817–822.
Zhu, F., Di, Y. T., Liu, L. L., et al. (2010). Cytotoxic neoclerodane diterpenoids from Scutellaria barbata. Journal of Natural Products, 73, 233–236.
Zhu, Y. P. (1998). Chinese materia medica: Chemistry, pharmacology and applications. Amsterdam, Netherlands: Harwood Academic, 1998.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Wong, B.Y., Wong, H.H. (2011). An Evidence-based Perspective of Scutellaria Barbata (Skullcap) for Cancer Patients. In: Cho, W. (eds) Evidence-based Anticancer Materia Medica. Evidence-based Anticancer Complementary and Alternative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0526-5_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-0526-5_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0525-8
Online ISBN: 978-94-007-0526-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)